Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced rectal cancer

PROSPECT: neoadjuvant CRT vs FOLFOX in locally advanced rectal cancerПодробнее

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with l...Подробнее

Total neoadjuvant therapy + pembrolizumab in locally-advanced rectal cancerПодробнее

FOLFOX with 5FUCRT is non-inferior to 5FUCRT for treatment of LARCПодробнее

Debate: Optimal Sequencing of Multimodality Treatment in Rectal Cancer - Radiation Oncologist's POVПодробнее

Total neoadjuvant treatment without surgery for locally advanced rectal cancerПодробнее

Locally advanced rectal cancer & total neoadjuvant therapy - Induction vs consolidation chemotherapyПодробнее

Total Neoadjuvant Therapy in Rectal Cancer in the Community Setting | 2022 Evolution ConferenceПодробнее

ESMO 2020 Highlights on neoadjuvant mFOLFIRINOX for T3-4 rectal cancer: The PRODIGE 23 studyПодробнее

Total Neoadjuvant Therapy for Rectal Cancer (Original 2020 data).Подробнее

Locally Advanced Rectal Cancer: PROSPECT TrialПодробнее

Neoadjuvant and adjuvant chemotherapy with TME in T3 rectal cancerПодробнее

Debate: Is observation without surgery reasonable for rectal cancers achieving a clinical CR? - YesПодробнее

Rectal Cancer and Neoadjuvant Chemoradiation - What's the Evidence?? | BTK/RAS-ACS Journal Club #10Подробнее

Neoadjuvant chemotherapy with CapeOx alone vs standard chemoradiotherapy (CRT) with Capecitabine...Подробнее

Prolonged course of neoadjuvant chemoradiation therapy in locally advanced rectal cancer patientsПодробнее

Journal Club - Locally advanced rectal cancer highly sensitive to single-agent PD-1 blockadeПодробнее

Complete response in a patient with locally advanced colon cancer after neoadjuvant treatmentПодробнее

FOxTROT: neoadjuvant FOLFOX chemotherapy in colorectal cancerПодробнее